152 related articles for article (PubMed ID: 30864229)
1. Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study.
Wang DD; Chen X; Li ZP
J Clin Pharm Ther; 2019 Aug; 44(4):611-617. PubMed ID: 30864229
[TBL] [Abstract][Full Text] [Related]
2. Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and pharmacogenetics.
Chen X; Wang DD; Xu H; Li ZP
Expert Rev Clin Pharmacol; 2020 May; 13(5):553-561. PubMed ID: 32452705
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling.
Zhang H; Bu F; Li L; Jiao Z; Ma G; Cai W; Zhuang X; Lin HS; Shin JG; Xiang X
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):331-340. PubMed ID: 28945011
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients.
Du Y; Song W; Xiong X; Ge W; Zhu H
Xenobiotica; 2022 Mar; 52(3):274-283. PubMed ID: 35502774
[TBL] [Abstract][Full Text] [Related]
6. In vivo to in vitro effects of six bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) on the CYP3A/P-glycoprotein-mediated absorption and metabolism of tacrolimus.
Qin XL; Chen X; Wang Y; Xue XP; Wang Y; Li JL; Wang XD; Zhong GP; Wang CX; Yang H; Huang M; Bi HC
Drug Metab Dispos; 2014 Jan; 42(1):193-9. PubMed ID: 24195812
[TBL] [Abstract][Full Text] [Related]
7. Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp.
Qin XL; Chen X; Zhong GP; Fan XM; Wang Y; Xue XP; Wang Y; Huang M; Bi HC
Phytomedicine; 2014 Apr; 21(5):766-72. PubMed ID: 24462213
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
[TBL] [Abstract][Full Text] [Related]
9. Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule.
Chen X; Wang D; Xu H; Li Z
J Clin Pharm Ther; 2020 Apr; 45(2):309-317. PubMed ID: 31755126
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus population pharmacokinetics according to CYP3A5 genotype and clinical factors in Chinese adult kidney transplant recipients.
Zhang HJ; Li DY; Zhu HJ; Fang Y; Liu TS
J Clin Pharm Ther; 2017 Aug; 42(4):425-432. PubMed ID: 28401703
[TBL] [Abstract][Full Text] [Related]
11. Model extrapolation to a real-world dataset: evaluation of tacrolimus population pharmacokinetics and drug interaction in pediatric liver transplantation patients.
Wang DD; Chen X; Fu M; Zheng QS; Xu H; Li ZP
Xenobiotica; 2020 Apr; 50(4):371-379. PubMed ID: 31192749
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study.
Wang DD; Lu JM; Li Q; Li ZP
J Clin Pharm Ther; 2018 Aug; 43(4):476-483. PubMed ID: 29766530
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.
Sam WJ; Aw M; Quak SH; Lim SM; Charles BG; Chan SY; Ho PC
Br J Clin Pharmacol; 2000 Dec; 50(6):531-41. PubMed ID: 11136292
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of tacrolimus in Chinese adult liver transplant patients.
Teng F; Zhang W; Wang W; Chen J; Liu S; Li M; Li L; Guo W; Wei H
Biopharm Drug Dispos; 2022 Apr; 43(2):76-85. PubMed ID: 35220592
[TBL] [Abstract][Full Text] [Related]
15. Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients.
Cheng F; Li Q; Wang J; Zeng F; Zhang Y
J Clin Pharm Ther; 2021 Dec; 46(6):1636-1649. PubMed ID: 34342024
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
[TBL] [Abstract][Full Text] [Related]
17. CYP2C19 is involved in the effect of Wuzhi tablet (
Yuan F; Liang X; Chen X; Qin X; Tan C; Wang L
Pharmazie; 2020 Nov; 75(11):559-564. PubMed ID: 33239129
[TBL] [Abstract][Full Text] [Related]
18. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients].
Zhang GM; Li L; Chen WQ; Bi SS; Liu X; Zhang XL; Lu W
Yao Xue Xue Bao; 2008 Jul; 43(7):695-701. PubMed ID: 18819472
[TBL] [Abstract][Full Text] [Related]
19. The Pharmacokinetic Prediction of Cyclosporin A after Coadministration with Wuzhi Capsule.
Fan J; Chen L; Lu X; Li M; Zhu L
AAPS PharmSciTech; 2019 Jul; 20(6):247. PubMed ID: 31286321
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients.
Chen B; Shi HQ; Liu XX; Zhang WX; Lu JQ; Xu BM; Chen H
J Clin Pharm Ther; 2017 Dec; 42(6):679-688. PubMed ID: 28833329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
